Raymond James Financial Inc. upgraded shares of Natus Medical Inc. (NASDAQ:BABY) from a market perform rating to an outperform rating in a report released on Tuesday morning. The brokerage currently has $46.00 price objective on the stock.
Separately, Zacks Investment Research upgraded shares of Natus Medical from a hold rating to a buy rating and set a $44.00 price objective for the company in a research note on Thursday, July 7th.
Natus Medical (NASDAQ:BABY) opened at 42.61 on Tuesday. The company has a market cap of $1.38 billion, a P/E ratio of 36.73 and a beta of 0.85. The firm’s 50 day moving average is $39.40 and its 200 day moving average is $36.44. Natus Medical has a 12-month low of $29.54 and a 12-month high of $51.05.
Natus Medical (NASDAQ:BABY) last posted its quarterly earnings data on Wednesday, July 20th. The company reported $0.39 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.36 by $0.03. Natus Medical had a net margin of 10.20% and a return on equity of 13.82%. The business earned $96 million during the quarter, compared to the consensus estimate of $92.71 million. During the same period in the previous year, the firm posted $0.34 earnings per share. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. Equities research analysts anticipate that Natus Medical will post $1.70 EPS for the current fiscal year.
A number of hedge funds and other institutional investors have recently bought and sold shares of BABY. Acrospire Investment Management LLC increased its position in Natus Medical by 39.1% in the second quarter. Acrospire Investment Management LLC now owns 2,844 shares of the company’s stock worth $108,000 after buying an additional 800 shares in the last quarter. BlackRock Inc. increased its position in Natus Medical by 36.0% in the second quarter. BlackRock Inc. now owns 3,096 shares of the company’s stock worth $117,000 after buying an additional 820 shares in the last quarter. Invictus RG acquired a new position in Natus Medical during the first quarter worth about $148,000. PineBridge Investments L.P. increased its position in Natus Medical by 3.7% in the second quarter. PineBridge Investments L.P. now owns 4,200 shares of the company’s stock worth $159,000 after buying an additional 149 shares in the last quarter. Finally, Teacher Retirement System of Texas increased its position in Natus Medical by 13.9% in the second quarter. Teacher Retirement System of Texas now owns 4,602 shares of the company’s stock worth $174,000 after buying an additional 562 shares in the last quarter. Institutional investors own 87.93% of the company’s stock.
Natus Medical Company Profile
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Receive News & Ratings for Natus Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.